Format

Send to

Choose Destination
Blood Cancer J. 2017 Feb 3;7(2):e525. doi: 10.1038/bcj.2017.6.

The role of the extracellular matrix in primary myelofibrosis.

Author information

1
Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA, USA.
2
Department of Molecular Medicine, University of Pavia, Pavia, Italy.
3
Laboratory of Biotechnology, IRCCS San Matteo Foundation, Pavia, Italy.

Abstract

Primary myelofibrosis (PMF) is a myeloproliferative neoplasm that arises from clonal proliferation of hematopoietic stem cells and leads to progressive bone marrow (BM) fibrosis. While cellular mutations involved in the development of PMF have been heavily investigated, noteworthy is the important role the extracellular matrix (ECM) plays in the progression of BM fibrosis. This review surveys ECM proteins contributors of PMF, and highlights how better understanding of the control of the ECM within the BM niche may lead to combined therapeutic options in PMF.

PMID:
28157219
PMCID:
PMC5386340
DOI:
10.1038/bcj.2017.6
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center